Deletion of Arf6 in endothelial cells abolishes hepatocyte growth factor-stimulated β1 integrin recycling, and pharmacological inhibition of the Arf6-GEF suppresses tumour angiogenesis and growth [27]. The gene discussed is ARF6; the disease is neoplasm.